Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population

ConclusionThe overall prevalence of inhibitors in patients with severe haemophilia A is similar to that reported among patients receiving regular replacement therapy. The data from this study, limited by its retrospective and cross ‐sectional study design, would suggest that genetic rather than environmental are more likely to impact the development of inhibitors. (Source: Haemophilia)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2PtfX4o